Virtual Conference will Showcase 3 Unique BioTech Companies from 1:00pm –
New York, NY – (NewMediaWire) – February 22, 2021 – TraDigital IR, a leading
investor relations, corporate communications and digital media firm, which
represents emerging growth public and private companies across multiple
sectors, today announced its partnership with Proactive Investors to sponsor the
ONE2ONE Virtual Investor Forum taking place on Tuesday, February 23, 2021. The
participating companies’ presentations will be held from 1:00pm ET – 2:00pm ET.
“Each of the three
companies presenting at Proactive’s ONE2ONE BioTech Virtual Investor Forum has
an innovative approach to its mission and providing solutions in the
psychedelic drugs market. With 15 minute presentations and networking among the
participants and a high quality group of investors, this is a great opportunity
for investors to get to know the managements and missions of these unique
companies,” said MJ Clyburn, Founder and CEO of TraDigital IR.
Interested investors may RSVP to Christine Corrado to attend.
The three participating life science companies
Silo Pharma: Biotech company in the developmental stage focused on merging traditional
therapeutics with psychedelic research for people suffering from indications
such as depression, PTSD, Parkinson’s, and other rare neurological disorders.
Lobe Sciences: Lobe Sciences is a company focused on
growth-oriented technologies with its core interest in transformational
medicines and wellness. In particular, the company is targeting the psychedelic
market in large part thanks to acquisitions and development of assets, products
Aion Therapeutic: The Company focuses on creating novel patent
protected therapeutic formulations using medical cannabis for the treatment of
patients with many types of illnesses including cancer, psychiatric disorders,
addiction, viral infections, obesity, and chronic inflammation. Aion Therapeutic
serves customers in Canada.
Founder & CEO